Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients

Oncology
Panagiotis SamarasBernhard C Pestalozzi

Abstract

We assessed longevity and complications of totally implantable venous access devices in oncology patients. 197 patients received a total of 201 port devices via the subclavian vein for delivery of chemotherapy between January 1, 2005, and December 31, 2006. We reviewed the patient charts for port-related complications and risk factors until July 31, 2007. A total of 47,781 catheter days were analyzed (median, 175 days; range, 1-831). Forty-six different complications occurred (0.96 complications/1,000 catheter days). The only risk factor significantly associated with a higher complication rate was younger age. Older patients had a lower risk for developing complications with a risk reduction of 2.4% for each year. There were no differences regarding underlying tumor, gender, access side, method of placement (subclavian/cephalic vein) or implanting team (thoracic versus visceral surgery). A trend was seen for shorter port longevity in hematologic patients compared to oncologic patients (p = 0.059). The former developed significantly more port-associated infections than solid tumor patients [11/53 cases (21%) versus 2/148 cases (1.4%); p < 0.0001]. Port-associated infections were mostly observed in younger patients with hematolog...Continue Reading

Citations

Mar 8, 2011·JPEN. Journal of Parenteral and Enteral Nutrition·Melissa A HullChristopher Duggan
Nov 23, 2013·The Pediatric Infectious Disease Journal·Etan OrgelReuven J Schore
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Deborah TomlinsonLillian Sung
Apr 27, 2012·Pediatric Blood & Cancer·Nitza NewmanEugene Leibovitz
Dec 10, 2013·The Lancet Infectious Diseases·David LebeauxChristophe Beloin
Dec 10, 2013·Diagnostic Microbiology and Infectious Disease·Emilio BouzaUNKNOWN GEIDI study group
Jul 24, 2014·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Jisue ShimSang Cheul Oh
May 9, 2012·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Se Jin AhnJae Hyung Park
Jan 21, 2017·American Journal of Clinical Oncology·Omidreza TabatabaieJennifer F Tseng
May 3, 2011·The Journal of Vascular Access·Ulf K M TeichgräberSebastian N Nagel
Feb 7, 2012·The Journal of Vascular Access·Evangelos PerdikakisDimitrios Tsetis
Mar 8, 2018·The Journal of Vascular Access·Fulvio PinelliMauro Pittiruti
Mar 12, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Ewelina GowinDanuta Januszkiewicz-Lewandowska
Apr 15, 2020·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Tyler S TancrediPeter N Waybill
Feb 2, 2010·The Journal of Vascular Access·Kenji NishinariGuilherme Yazbek
Nov 15, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Shigeaki TsurutaJunichi Takamizawa
Oct 6, 2020·Indian Journal of Surgical Oncology·Kumar M VinchurkarVishwanath M Pattanshetti
Feb 13, 2016·Pediatric Blood & Cancer·I Fernandez-PinedaA M Davidoff
Jan 29, 2020·Journal of the Chinese Medical Association : JCMA·Chia-Yu KaoJyh-Wen Chai
Mar 29, 2011·Deutsches Ärzteblatt International·Ulf K TeichgräberHerbert A F Hofmann
Aug 15, 2020·Journal of Vascular and Interventional Radiology : JVIR·Philip SkummerMohammed Jawed
Sep 4, 2017·Revue de l'infirmière·Julie BugeaudNathalie Thibault

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.